
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 162087
[patent_doc_number] => 07670785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Polynucleotides and polypeptides associated with the development of rheumatoid arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/811442
[patent_app_country] => US
[patent_app_date] => 2007-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 105
[patent_no_of_words] => 13678
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/670/07670785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11811442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/811442 | Polynucleotides and polypeptides associated with the development of rheumatoid arthritis | Jun 6, 2007 | Issued |
Array
(
[id] => 4853113
[patent_doc_number] => 20080318856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'MONOMER PROTEIN WITH BONE MORPHOGENETIC ACTIVITY AND MEDICINAL AGENT CONTAINING THE SAME FOR PREVENTING AND TREATING DISEASES OF CARTILAGE AND BONE'
[patent_app_type] => utility
[patent_app_number] => 11/758878
[patent_app_country] => US
[patent_app_date] => 2007-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4245
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11758878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/758878 | Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone | Jun 5, 2007 | Issued |
Array
(
[id] => 6235441
[patent_doc_number] => 20100267145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'IMMUNOCOMPETENT CELL HAVING ANTI-CD38 ANTIBODY ON ITS CELL SURFACE'
[patent_app_type] => utility
[patent_app_number] => 12/303498
[patent_app_country] => US
[patent_app_date] => 2007-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10134
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267145.pdf
[firstpage_image] =>[orig_patent_app_number] => 12303498
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/303498 | IMMUNOCOMPETENT CELL HAVING ANTI-CD38 ANTIBODY ON ITS CELL SURFACE | Jun 4, 2007 | Abandoned |
Array
(
[id] => 4651018
[patent_doc_number] => 20080038274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Inhibition of secretion from non-neuronal cells'
[patent_app_type] => utility
[patent_app_number] => 11/806648
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21461
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11806648
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/806648 | Inhibition of secretion from non-neuronal cells | May 31, 2007 | Abandoned |
Array
(
[id] => 4733331
[patent_doc_number] => 20080050310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 11/754899
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 89304
[patent_no_of_claims] => 238
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11754899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/754899 | Antibodies and immunoconjugates and uses therefor | May 28, 2007 | Issued |
Array
(
[id] => 5943438
[patent_doc_number] => 20110104058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'DIMERIC MOLECULAR COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/302283
[patent_app_country] => US
[patent_app_date] => 2007-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8265
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104058.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302283 | Dimeric molecular complexes | May 23, 2007 | Issued |
Array
(
[id] => 5010457
[patent_doc_number] => 20070280936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'METHOD FOR TREATING PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 11/753498
[patent_app_country] => US
[patent_app_date] => 2007-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1642
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11753498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/753498 | METHOD FOR TREATING PSORIASIS | May 23, 2007 | Abandoned |
Array
(
[id] => 5464411
[patent_doc_number] => 20090324611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/299672
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24834
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324611.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299672
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299672 | Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases | May 16, 2007 | Issued |
Array
(
[id] => 4778339
[patent_doc_number] => 20080286337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Method of treating a disease in an eye using a scleral lens'
[patent_app_type] => utility
[patent_app_number] => 11/803709
[patent_app_country] => US
[patent_app_date] => 2007-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3770
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11803709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/803709 | Method of treating a disease in an eye using a scleral lens | May 14, 2007 | Abandoned |
Array
(
[id] => 4779917
[patent_doc_number] => 20080287915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Tissue engineering system with scleral lens'
[patent_app_type] => utility
[patent_app_number] => 11/803701
[patent_app_country] => US
[patent_app_date] => 2007-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3734
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11803701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/803701 | Tissue engineering system with scleral lens | May 14, 2007 | Abandoned |
Array
(
[id] => 4812814
[patent_doc_number] => 20080193445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Novel anti-IGF-IR antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/801080
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 60408
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11801080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/801080 | Novel anti-IGF-IR antibodies and uses thereof | May 7, 2007 | Abandoned |
Array
(
[id] => 5551840
[patent_doc_number] => 20090285826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'COMBINATION DRUGS COMPRISING VEGF INHIBITOR AND SERINE PROTEASES/THROMBOLYTIC COMPOUNDS FOR TREATING NEOVASCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/299412
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8193
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285826.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299412 | COMBINATION DRUGS COMPRISING VEGF INHIBITOR AND SERINE PROTEASES/THROMBOLYTIC COMPOUNDS FOR TREATING NEOVASCULAR DISORDERS | May 3, 2007 | Abandoned |
Array
(
[id] => 5259757
[patent_doc_number] => 20070213389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Process and substances for the release of a growth-regulating factor from endothelial cells'
[patent_app_type] => utility
[patent_app_number] => 11/799287
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8617
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799287
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799287 | Process and substances for the release of a growth-regulating factor from endothelial cells | Apr 30, 2007 | Abandoned |
Array
(
[id] => 4458934
[patent_doc_number] => 07879334
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-02-01
[patent_title] => 'Fusion molecules and treatment of IgE-mediated allergic diseases'
[patent_app_type] => utility
[patent_app_number] => 11/799442
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20405
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799442 | Fusion molecules and treatment of IgE-mediated allergic diseases | Apr 29, 2007 | Issued |
Array
(
[id] => 5485283
[patent_doc_number] => 20090275048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'ANTI-ACHARAN SULFATE ANTIBODY AND ITS APPLICATION'
[patent_app_type] => utility
[patent_app_number] => 12/297048
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9436
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297048
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297048 | Anti-acharan sulfate antibody and its application | Apr 26, 2007 | Issued |
Array
(
[id] => 5062558
[patent_doc_number] => 20070224197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Three-dimensional structure of complement receptor type 2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/786788
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 124038
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786788 | Three-dimensional structure of complement receptor type 2 and uses thereof | Apr 11, 2007 | Issued |
Array
(
[id] => 4704116
[patent_doc_number] => 20080063639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/783666
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 45004
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063639.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783666 | Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodies | Apr 10, 2007 | Abandoned |
Array
(
[id] => 4778200
[patent_doc_number] => 20080286198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Novel anti-IGF-IR antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/783513
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 41668
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783513 | Anti-IGF-IR antibodies and uses thereof | Apr 9, 2007 | Issued |
Array
(
[id] => 5015768
[patent_doc_number] => 20070258976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Combination Therapy for Diseases Involving Angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/733282
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11166
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258976.pdf
[firstpage_image] =>[orig_patent_app_number] => 11733282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/733282 | Combination Therapy for Diseases Involving Angiogenesis | Apr 9, 2007 | Abandoned |
Array
(
[id] => 4579964
[patent_doc_number] => 07850963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Vascular endothelial growth factor 2'
[patent_app_type] => utility
[patent_app_number] => 11/730696
[patent_app_country] => US
[patent_app_date] => 2007-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 68
[patent_no_of_words] => 101151
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/850/07850963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11730696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/730696 | Vascular endothelial growth factor 2 | Apr 2, 2007 | Issued |